نتایج جستجو برای: psa kinetics

تعداد نتایج: 108543  

ژورنال: :مجله دانشکده پزشکی دانشگاه علوم پزشکی مشهد 0
علی علی عبدالحسینی ali abdolhoseini general physician, mashhad, iranپزشک عمومی، مشهد، ایران کامبیز کامبیز توتونچی صراف kambiz tootoonchi sarraf general physician, mashhad, iranپزشک عمومی، مشهد، ایران عذرا عذرا ایزانلو azra izanloo ma of medical education, mashhad, iranکارشناسی ارشد آموزش پزشکی، مشهد، ایران نجمه نجمه جعفری مقدم najmeh jafari moghadam ba of medical records, mashhad, iranکارشناس مدارک پزشکی، مشهد، ایران

مقدمه آستانه خاص آنتی‏ژن اختصاصی پروستات (psa) برای مشخص نمودن بیماران در معرض بالاترین خطر ابتلا به سرطان پروستات همیشه بحث برانگیز بوده است. این مطالعه با هدف بررسی میزان مقادیر psa بر اساس سن و بررسی رابطه psa و  نمایه توده بدن (bmi) و حجم و اندازه پروستات در افراد بدون علامت  انجام شده است. روش کار در این مطالعه توصیفی از اطلاعات دموگرافیک و مقادیر psa توتال و اندازه‏های به دست آمده پروستات...

Ali Davati Fatemeh Ghafarirad Hossin Ayatollahi Maryam Maleki Mohammad Hassan Ghosian Moghaddam,

Background and Objective: Prostate cancer is a prevalent disease around the world. The prostatic specific Antigen (PSA) test has recently proved itself as a useful method for the diagnosis and examination of patients with prostatic cancer. The objective of this study was to compare the stability of free PSA and total PSA in different storage settings. Materials and Method...

توکل نیا, دکتررحیم, روشنی, دکتر علی,

ABSTRACT Prostate specific antigen (PSA) is a specific marker of prostate tumor which is used for diagnosis of prostate cancer. Apart from prostate cancer,different factors may affect PSA level and ejaculation is one of these possible factors .In a study on 21 patients at ages of 18-37, serum levels of PSA were measured before the ejaculation and about two hours after it. There was no statisti...

Journal: :nephro-urology monthly 0
mohammadreza nowroozi uro-oncology research center, tehran university of medical sciences, tehran, ir iran mohsen ayati uro-oncology research center, tehran university of medical sciences, tehran, ir iran hassan jamshidian uro-oncology research center, tehran university of medical sciences, tehran, ir iran amir arbab uro-oncology research center, tehran university of medical sciences, tehran, ir iran hamidreza ghorbani uro-oncology research center, tehran university of medical sciences, tehran, ir iran; uro-oncology research center, tehran university of medical sciences, tehran, ir iran. tel/fax: +98-2166903063 erfan amini uro-oncology research center, tehran university of medical sciences, tehran, ir iran

conclusions using tzpsad as an adjunct to psa may improve the specificity of psa in the diagnosis of pca and decrease the number of unnecessary prostatic biopsies in iranian men with serum psa level < 20 ng/ml. results among 1120 men who were eligible for enrolment, prostate cancer was detected in 265 patients. mean serum psa levels were 9.7 ± 4.3 ng/ml and 8.5 ± 3.7 ng/ml in patients with and ...

Journal: :iranian journal of immunology 0
abdol aziz khezri shiraz institute for cancer research mehdi shirazi department of urology seyyed mohammad taghi ayatollahi department of biostatistics mehrzad lotfi department of radiology mehrdad askarian department of community medicine, shiraz university of medical sciences, shiraz, iran ali ariafar department of urology mohammad amin afrasiabi

background: it is relevant to highlight that there is not a precise and perfect report on either 95 percentile value (upper limit of normal range) or on appropriate reference intervals for serum psa in iranian population. objective: to determine age-specific reference ranges for serum prostate-specific antigen (psa) concentration and psa density (psad) and prostate volumes in a population of he...

رضا نجفی محمد شفیعی محمدحسین بابایی مسعود مولا هاله فروتن پیام بهرادکیا

روش‌های تعیین غلظت پادگن ویژه پروستات (PSA) در خون که شاخصی انتخابی برای تشخیص سرطان پروستات و پیگیری درمان آنند, اغلب بر اساس سنجش ایمن‌شناختی خاص پایه‌گذاری شده‌اند؛ در این روش‌ها از ایجاد کمپلکس پادگن- پادتن برای تعیین مقدار PSA استفاده می‌شود. با انجام دادن این تحقیق, پادگن PSA به مقدار کافی بصورت نیمه‌خالص و خالص تهیه شد که ماده‌ای ارزشمند در تهیه استاندارد برای کیت‌های تشخیصی PSA می‌باشد؛...

  MR Mohammadi Fallah [1] , MD S Jafari [2] , MD M Alizadeh [3] , MD MR Mokhtari [4] , MD    Received: 14 April, 2007 Accepted: 1 May, 2008   ABSTRACT:   Background & Aims: Prostate cancer is the most common male malignancy. Today, patients are screened with PSA and DRE, and in the presence of high PSA level (>4 ng/ml) or abnormal DRE finding, TRUS guided biopsy of prostate is performed for def...

Journal: :iranian journal of public health 0
xin liu jie tang xiang fei qiu-yang li

background: we aimed to value the usefulness of free to total prostate-specific antigen and prostate-specific antigen (psa) density for prostate cancer in the patients with psa levels of 4.0 ng/ml or less. methods: a total of 343 subjects with psa levels of 4.0 ng/ml or less were biopsied. all patients were divided into four groups according to the psa levels: 0 to 1.0 ng/ml, 1.1 to 2.0 ng/ml, ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید